Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2019

Open Access 01-12-2019 | Peritoneal Dialysis | Protocol

Association of incident dialysis modality with mortality: a protocol for systematic review and meta-analysis of randomized controlled trials and cohort studies

Authors: Mark R. Marshall, Chun-Yuan Hsiao, Philip K. Li, Masaaki Nakayama, S. Rabindranath, Rachael C. Walker, Xueqing Yu, Suetonia C. Palmer

Published in: Systematic Reviews | Issue 1/2019

Login to get access

Abstract

Background

At least 2.6 million adults and children receive dialysis treatment for end-stage kidney disease (ESKD) worldwide. The large majority of these receive hemodialysis (HD), while the remaining receive peritoneal dialysis (PD). Peritoneal dialysis may be associated with similar mortality outcomes as HD, and patient-reported outcomes are potentially increased with PD. Existing evidence for the mortality associated with PD was summarized over 20 years ago, and there has been greater marginal improvement in survival with PD relative to HD since that time. It is therefore timely to reexamine the question of differential mortality by modality and summarize evidence from more contemporary practice settings.

Methods/design

Electronic databases will be systematically searched for publications that report the association between dialysis modality (HD or PD) with death from any cause and cause-specific death in incident patients with end-stage kidney disease. The database searches will be supplemented by searching through citations and references and consultation with experts. Studies published before 1995 will be excluded. Screening of both titles and abstracts will be done by two independent reviewers. All disagreements will be resolved by an independent third reviewer. A quantitative meta-analysis of effect sizes and standard errors will be applied.

Discussion

Our systematic review will update previous evidence summaries and provide a quantitative and standardized assessment of the contemporary literature comparing HD and PD including published and unpublished non-English studies from greater China, Taiwan, and Japan. This review will inform shared decision-making around initial dialysis modality choice and jurisdiction-level considerations of dialysis practice.

Systematic review registration

PROSPERO CRD42018111829
Appendix
Available only for authorised users
Literature
1.
Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.PubMedCrossRef
2.
Merchant AA, Quinn RR, Perl J. Dialysis modality and survival: does the controversy live on? Curr Opin Nephrol Hypertens. 2015;24(3):276–83.PubMedCrossRef
3.
Teixeira JP, Combs SA, Teitelbaum I. Peritoneal dialysis: update on patient survival. Clin Nephrol. 2015;83:1):1–10.PubMed
4.
Trinh E, Chan CT, Perl J. Dialysis modality and survival: done to death. Semin Dial. 2018;31(4):315–24.PubMedCrossRef
5.
Wasserfallen JB, Moinat M, Halabi G, Saudan P, Perneger T, Feldman HI, Martin PY, Wauters JP. Satisfaction of patients on chronic haemodialysis and peritoneal dialysis. Swiss Med Wkly. 2006;136(13–14):210–7.PubMed
6.
Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. Jama. 2004;291(6):697–703.PubMedCrossRef
7.
Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol. 2006;1(6):1191–6.PubMedCrossRef
8.
Tong A, Lesmana B, Johnson DW, Wong G, Campbell D, Craig JC. The perspectives of adults living with peritoneal dialysis: thematic synthesis of qualitative studies. Am J Kidney Dis. 2013;61(6):873–88.PubMedCrossRef
9.
Brown EA, Johansson L, Farrington K, Gallagher H, Sensky T, Gordon F, Da Silva-Gane M, Beckett N, Hickson M. Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant. 2010;25(11):3755–63.PubMedPubMedCentralCrossRef
10.
Zazzeroni L, Pasquinelli G, Nanni E, Cremonini V, Rubbi I. Comparison of quality of life in patients undergoing hemodialysis and peritoneal dialysis: a systematic review and meta-analysis. Kidney Blood Pressure Res. 2017;42(4):717–27.CrossRef
11.
Boateng EA, East L. The impact of dialysis modality on quality of life: a systematic review. J Renal Care. 2011;37(4):190–200.CrossRef
12.
Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9(9):e1001307.PubMedPubMedCentralCrossRef
13.
Dale PL, Hutton J, Elgazzar H. Utility of health states in chronic kidney disease: a structured review of the literature. Curr Med Res Opin. 2008;24(1):193–206.PubMedCrossRef
14.
Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health. 2008;11(4):733–41.PubMedCrossRef
15.
Kutner NG, Zhang R, Huang Y, Johansen KL. Depressed mood, usual activity level, and continued employment after starting dialysis. Clin J Am Soc Nephrol. 2010;5(11):2040–5.PubMedPubMedCentralCrossRef
16.
Pike E, Hamidi V, Ringerike T, Wisloff T, Klemp M. More use of peritoneal dialysis gives significant savings: a systematic review and health economic decision model. J Clin Med Res. 2017;9(2):104–16.PubMedCrossRef
17.
Muehrer RJ, Schatell D, Witten B, Gangnon R, Becker BN, Hofmann RM. Factors affecting employment at initiation of dialysis. Clin J Am Soc Nephrol. 2011;6(3):489–96.PubMedPubMedCentralCrossRef
18.
Julian Mauro JC, Molinuevo Tobalina JA, Sanchez Gonzalez JC. Employment in the patient with chronic kidney disease related to renal replacement therapy. Nefrologia. 2012;32(4):439–45.PubMed
19.
Helantera I, Haapio M, Koskinen P, Gronhagen-Riska C, Finne P. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland. Am J Kidney Dis. 2012;59(5):700–6.PubMedCrossRef
20.
Nakayama M, Ishida M, Ogihara M, Hanaoka K, Tamura M, Kanai H, Tonozuka Y, Marshall MR. Social functioning and socioeconomic changes after introduction of regular dialysis treatment and impact of dialysis modality: a multi-centre survey of Japanese patients. Nephrology (Carlton). 2015;20(8):523–30.CrossRef
21.
Walker RC, Marshall R, Howard K, Morton RL, Marshall MR. "Who matters most?": Clinician perspectives of influence and recommendation on home dialysis uptake. Nephrology (Carlton). 2017;22(12):977–84.CrossRef
22.
Machowska A, Rutherford P. Peritoneal dialysis use within the context of the population and healthcare systems of Europe - differences, trends and future challenges. Int J Artif Organs. 2016;39(5):211–9.PubMedCrossRef
23.
Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Relation between pediatric experience and treatment recommendations for children and adolescents with kidney failure. Jama. 2001;285(8):1027–33.PubMedCrossRef
24.
Bouvier N, Durand PY, Testa A, Albert C, Planquois V, Ryckelynck JP, Lobbedez T. Regional discrepancies in peritoneal dialysis utilization in France: the role of the nephrologist's opinion about peritoneal dialysis. Nephrol Dial Transplant. 2009;24(4):1293–7.PubMedCrossRef
25.
Manns B, Agar JWM, Biyani M, Blake PG, Cass A, Culleton B, Kleophas W, Komenda P, Lobbedez T, MacRae J, et al. Can economic incentives increase the use of home dialysis? Nephrol Dial Transplant. 2018. https://​doi.​org/​10.​1093/​ndt/​gfy223. [Epub ahead of print].
26.
Hirth RA, Turenne MN, Wheeler JR, Nahra TA, Sleeman KK, Zhang W, Messana JA. The initial impact of Medicare’s new prospective payment system for kidney dialysis. Am J Kidney Dis. 2013;62(4):662–9.PubMedCrossRef
27.
Fortnum D, Ludlow M, Morton RL. Renal unit characteristics and patient education practices that predict a high prevalence of home-based dialysis in Australia. Nephrology (Carlton). 2014;19(9):587–93.CrossRef
28.
Mann BS, Manns BJ, Barnieh L, Oliver MJ, Devoe D, Lorenzetti D, Pauly R, Quinn RR. Peritoneal dialysis: a scoping review of strategies to maximize PD utilization. Perit Dial Int. 2017;37(2):159–64.PubMedCrossRef
29.
Dahlan R, Qureshi M, Akeely F, Al Sayyari AA. Barriers to peritoneal dialysis in Saudi Arabia: nephrologists’ perspectives. Perit Dial Int. 2016;36(5):564–6.PubMedPubMedCentralCrossRef
30.
Ross S, Dong E, Gordon M, Connelly J, Kvasz M, Iyengar M, Mujais SK. Meta-analysis of outcome studies in end-stage renal disease. Kidney Int. 2000;57:S28–38.CrossRef
31.
Gutman RA, Blumenkrantz MJ, Chan YK, Barbour GL, Gandhi VC, Shen FH, Tucker T, Murawski BJ, Coburn JW, Curtis FK. Controlled comparison of hemodialysis and peritoneal dialysis: Veterans Administration multicenter study. Kidney Int. 1984;26(4):459–70.PubMedCrossRef
32.
Marshall MR, Polkinghorne KR, Kerr PG, Agar JW, Hawley CM, McDonald SP. Temporal changes in mortality risk by dialysis modality in the Australian and New Zealand dialysis population. Am J Kidney Dis. 2015;66(3):489–98.PubMedCrossRef
33.
Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L. Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol. 2011;22(6):1113–21.PubMedPubMedCentralCrossRef
34.
Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568–75.PubMedCrossRef
35.
Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med. 2011;171(2):110–8.PubMedCrossRef
36.
Treamtrakanpon W, Katavetin P, Yimsangyad K, Keawsinark P, Sanganunttakan S, Pandon S, Buddeewong D, Prakot A, Khumsupo C, Thamsutee N, et al. From the “PD First” policy to the innovation in PD care. J Med Assoc Thai. 2011;94(Suppl 4):S13–8.PubMed
37.
Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int. 2007;71(2):153–8.PubMedCrossRef
38.
Heaf JG, Wehberg S. Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation. PLoS One. 2014;9(3):e90119.PubMedPubMedCentralCrossRef
39.
Chang YK, Hsu CC, Hwang SJ, Chen PC, Huang CC, Li TC, Sung FC. A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Medicine. 2012;91(3):144–51.PubMedCrossRef
40.
Ryu J-H, Kim H, Kim KH, Hann HJ, Ahn HS, Lee S, Kim S-J, Kang D-H, Choi KB, Ryu D-R. Improving survival rate of Korean patients initiating Dialysis. Yonsei Med J. 2015;56(3):666–75.PubMedPubMedCentralCrossRef
41.
Pike E, Hamidi V, Ringerike T, Wisloff T, Desser A, Harboe I, Klemp M. NIPH systematic reviews. In: Health technology assessment of the different dialysis modalities in Norway. Oslo: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2013.
42.
Sinclair A, Cimon K, Loncar M, Sood M, Komenda P, Severn M, Klarenbach S, So H, Tsoi B, Quinn R, et al. Dialysis modalities for the treatment of end-stage kidney disease: a health technology assessment. In: CADTH Optimal Use Report. vol. 6. Ottawa: CADTH; 2018.
43.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.PubMedPubMedCentralCrossRef
44.
45.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.PubMedCrossRef
46.
International Monetary Fund. World Economic Outlook: Challenges to Steady Growth. Washington, DC: International Monetary Fund, Publication Services; 2018.
47.
Marshall MR, Hawley CM, Kerr PG, Polkinghorne KR, Marshall RJ, Agar JW, McDonald SP. Home hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis. 2011;58(5):782–93.PubMedCrossRef
48.
Marshall MR, Polkinghorne KR, Kerr PG, Hawley CM, Agar JW, McDonald SP. Intensive hemodialysis and mortality risk in Australian and New Zealand populations. Am J Kidney Dis. 2016;67(4):617–28.PubMedCrossRef
49.
Marshall MR, van der Schrieck N, Lilley D, Supershad SK, Ng A, Walker RC, Dunlop JL. Independent community house hemodialysis as a novel dialysis setting: an observational cohort study. Am J Kidney Dis. 2013;61(4):598–607.PubMedCrossRef
50.
51.
Vonesh EF, Schaubel DE, Hao W, Collins AJ. Statistical methods for comparing mortality among ESRD patients: examples of regional/international variations. Kidney Int. 2000;57:S19–27.CrossRef
52.
Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, Vist GE, Falck-Ytter Y, Meerpohl J, Norris S, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–6.PubMedCrossRef
Metadata
Title
Association of incident dialysis modality with mortality: a protocol for systematic review and meta-analysis of randomized controlled trials and cohort studies
Authors
Mark R. Marshall
Chun-Yuan Hsiao
Philip K. Li
Masaaki Nakayama
S. Rabindranath
Rachael C. Walker
Xueqing Yu
Suetonia C. Palmer
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2019
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-019-0972-1

Other articles of this Issue 1/2019

Systematic Reviews 1/2019 Go to the issue

Protocol

Interventions to promote patients and families’ involvement in adult intensive care settings: a protocol for a mixed-method systematic review

Protocol

The association between diabetes and age at the onset of menopause: a systematic review protocol

Protocol

Loneliness and social isolation causal association with health-related lifestyle risk in older adults: a systematic review and meta-analysis protocol

Research

Usability and acceptability of four systematic review automation software packages: a mixed method design

Research

Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa—a systematic review and meta-analysis

Protocol

Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol